Angiotensin II receptor blockers (ARBs) were able to reduce aortic aneurysm expansion more effectively than angiotensin-converting enzyme inhibitors, suggesting that the angiotensin II type 1 receptor (AT1-R) plays an important role in the development of aortic dissection.5 This evidence concerns the gene AGTR1 and aortic aneurysm.